The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Gene expression signatures (GES) derived from digital histology to predict pathologic complete response (pCR) to neoadjuvant chemotherapy (CT) in ISPY2 and other trial/real world cohorts.
 
Frederick Howard
Consulting or Advisory Role - Novartis
 
Raghunath Babu
No Relationships to Disclose
 
James Dolezal
Stock and Other Ownership Interests - Slideflow Labs
 
Dezheng Huo
No Relationships to Disclose
 
Alexander Borowsky
Leadership - Histolix
Stock and Other Ownership Interests - Histolix
Consulting or Advisory Role - Tempus
Research Funding - Danaher (Inst)
 
W. Fraser Symmans
Stock and Other Ownership Interests - Delphi Diagnostics; Eiger BioPharmaceuticals; ISIS Pharmaceuticals
Consulting or Advisory Role - AstraZeneca; SAGA Diagnostics
Patents, Royalties, Other Intellectual Property - Intellectual property; Intellectual Property (expired); Intellectual Property (pending)
(OPTIONAL) Uncompensated Relationships - Delphi Diagnostics
 
Michael Campbell
Employment - Gilead Sciences (I)
Stock and Other Ownership Interests - Gilead Sciences (I)
Research Funding - Gilead Sciences (I)
Patents, Royalties, Other Intellectual Property - Royalties from a monoclonal antibody developed while at Stanford University.
Travel, Accommodations, Expenses - Gilead Sciences (I)
 
Denise Wolf
No Relationships to Disclose
 
Gillian Hirst
No Relationships to Disclose
 
Sara Venters
No Relationships to Disclose
 
Adam Asare
No Relationships to Disclose
 
Sai Kanaparthi
No Relationships to Disclose
 
Kim Blenman
Research Funding - Carevive; SimBioSys
 
Naing Lin Shan
No Relationships to Disclose
 
Charles Perou
Leadership - GeneCentric
Stock and Other Ownership Interests - Bioclassifier; GeneCentric; Reveal Genomics
Consulting or Advisory Role - Bioclassifier; GeneCentric; NanoString Technologies; Reveal Genomics; Veracyte
Patents, Royalties, Other Intellectual Property - royalties from PAM50 breast cancer gene patent application, and from lung gene signature patent
 
Laura Esserman
Consulting or Advisory Role - Blue Cross Blue Shield Association
Research Funding - Moderna Therapeutics (Inst)
Travel, Accommodations, Expenses - Blue Cross Blue Shield Association
(OPTIONAL) Uncompensated Relationships - Quantum Leap Healthcare Collaborative
 
Laura van t Veer
Employment - Agendia
Stock and Other Ownership Interests - Agendia; Exai Bio
 
Lajos Pusztai
Stock and Other Ownership Interests - Ataraxis
Honoraria - Agendia; AstraZeneca; Bristol-Myers Squibb; Merck @ Co; natera; Radionetics
Consulting or Advisory Role - Agendia; AstraZeneca; Bristol Myers Squibb; Merck; Natera; Personalis; Radionetics
Research Funding - Agendia (Inst); AstraZeneca (Inst); Bristol Myers Squibb (Inst); Exact Sciences (Inst); Menarini (Inst); Merck (Inst); Natera (Inst); Personalis (Inst); Pfizer (Inst)
(OPTIONAL) Uncompensated Relationships - Caris Life Sciences; Foundation Medicine
 
Rita Nanda
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Exact Sciences; GE Healthcare; Gilead Sciences; Guardant Health; Merck; Moderna Therapeutics; Novartis; Sanofi; Seagen; Stemline Therapeutics; Summit Therapeutics
Research Funding - Arvinas (Inst); AstraZeneca (Inst); Celgene (Inst); Corcept Therapeutics (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Merck (Inst); OBI Pharma (Inst); Odonate Therapeutics (Inst); OncoSec (Inst); Pfizer (Inst); Relay Therapeutics (Inst); Seagen (Inst); Sun Pharma (Inst); Taiho Oncology (Inst)
Other Relationship - G1 Therapeutics
 
Alexander Pearson
Honoraria - Caris Life Sciences
Consulting or Advisory Role - Abbvie; Ayala Pharmaceuticals; Elevar Therapeutics; Prelude Therapeutics; Thermo Fisher Scientific
Research Funding - Abbvie (Inst); EMD Serono (Inst); Kura Oncology (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Caris Life Sciences
 
ISPY2 Investigators
No Relationships to Disclose